P2s: Practice-changing, Paradigm-shifting Clinical Trials in Urology: Topline Results From PIVOT-006- A Phase 3, Randomized Controlled Study of Adjuvant Intravesical Cretostimogene Grenadenorepvec versus Surveillance for Intermediate-Risk Non-Muscle Invas
Friday, May 15, 2026 10:40 AM to 10:50 AM · 10 min. (America/New_York)
Hall D
Detail
Speakers
Max Kates
Johns HopkinsRegistered attendees
Eugene Pietzak
Urologic OncologistMemorial Sloan Kettering Cancer Center
Ignacio Tobia Gonzalez
Associate Profesor Urology Department Hospital Italiano de Buenos AiresLatin Ametrican Renal Cancer Group
Mark Schoenberg
Professor & Chair, Dept of Urology,The Dept of Urology The Montefiore Medical Cntr